Track topics on Twitter Track topics that are important to you
REPLICor is focused on discovering and developing a technology based upon the biological mechanisms of the initiation of DNA replication. Notwithstanding its focus, the company has access to a broadly applicable technology for the fields of gene therapy vectors, novel therapeutics and drug discovery tools. The company is currently working in three programs: i) Gene Therapy involving a platform technology based on the origin of DNA replication consensus sequence for gene therapy vectors; ii) Modulation of Cell Division for the development of target proteins and lead compounds targeting DNA replication for cancer and tissue regeneration; and iii) Screening & Designing concerning an enabling drug discovery methodology for discovery of new drugs for cancer and tissue regeneration.
1550 Metcalfe, Suite 502
Phone: 514 842 9849
Fax: 514 842 1505
MENLO PARK, CA -- (Marketwired) -- 05/04/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre...
LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of propri...
Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...
Replicor is a privately held biopharmaceutical company with the most advanced animal and human clinical data in the development of the cure for HBV and HDV. The company is dedicat...
REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV,...
REPLICor is focused on discovering and developing a technology based upon the biological mechanisms of the initiation of DNA replication. Notwithstanding its focus, the company has access to a broadly...
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
Founded in 2008 by the Axis Biotec Brasilâ¢ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....
We have published hundreds of REPLICor Incorporated news stories on BioPortfolio along with dozens of REPLICor Incorporated Clinical Trials and PubMed Articles about REPLICor Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of REPLICor Incorporated Companies in our database. You can also find out about relevant REPLICor Incorporated Drugs and Medications on this site too.
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...